Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford surgeons have devised a course to train healthcare providers in Africa to effectively treat children with clubfoot in under resourced situations.

Baby with clubfoot.

More than 30,000 children in Africa are born with clubfoot each year. Many thousands of these children will not receive treatment, as it is not available where they live.

 

We are very excited by the opportunity to completely change the lives of children and families, by training many more healthcare providers to treat more children with clubfoot. - Professor Chris Lavy

Without treatment, the condition becomes 'neglected clubfoot', a painful and severely disabling deformity. However, in up to 95% of cases, clubfoot can be treated successfully using the Ponseti method, especially if this is initiated early. The Ponseti method involves gentle manipulations of the foot and serial plaster casting over a period of about six weeks, then a very small outpatient procedure to divide a tight tendon. The child then needs to wear a brace for a short time to prevent recurrence.

We are raising £100,000 to deliver clubfoot training to healthcare providers in Africa, transforming the lives of thousands of children across the continent.

Professor Chris Lavy, at the University of Oxford, has worked with children with clubfoot for the last 20 years, both in the UK and Africa. He currently leads the Africa Clubfoot Training Project, a project that is strengthening training and delivery capacity for clubfoot treatment in 18 countries in sub-Saharan Africa, helping more children have access to much needed clubfoot treatment.

Chris says: "We are very excited by the opportunity to completely change the lives of children and families, by training many more healthcare providers to treat more children with clubfoot."

Researchers, surgeons, and physiotherapists from the University of Oxford and the Nuffield Orthopaedic Centre have developed two courses for healthcare professionals - one to train providers to delivering treatment to children with clubfoot, and one to train new instructors.

Working with our partners across Africa, we devised a two-day Basic Clubfoot Treatment Provider training course based on the Ponseti technique, and designed especially for under-resourced situations.

In many African countries there are shortages of healthcare providers, and our course focuses on key essentials to accommodate this reality. We have shown that healthcare providers who have no specialised physiotherapy or orthopaedic training can effectively deliver treatment for clubfoot.

Our Clubfoot 'Train The Trainer' course addresses the shortage of healthcare providers further. It trains new instructors in the knowledge and skills necessary to teach the basic course.

We aim to give every child with clubfoot the opportunity to have treatment, as we roll out two courses across Africa, a Basic Clubfoot Treatment Provider training course and a Clubfoot 'Train The Trainer' course.

The 4-week campaign runs from Monday 7 November to Sunday 4 December, at https://oxreach.hubbub.net/p/clubfoot/.

Support us

DONATE HERE.

The 4-week campaign runs from Monday 7 November to Sunday 4 December.

 

SPREAD THE WORD

On Twitter @ndorms #africaclubfoot

On Facebook

Tell all your friends, family, acquaintances.

 

BIG BIG BIG THANK YOU!

 

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).